{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T07:43:14Z","timestamp":1791186194832,"version":"4.1.0"},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,3,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Rationale<\/jats:title>\n                    <jats:p>Up to 10% of patients with systemic sclerosis (SSc) develop pulmonary arterial hypertension (PAH). This risk persists throughout the disease and is time dependent, suggesting that SSc is a susceptibility factor. Outcome for SSc-PAH is poor compared with heritable or idiopathic forms, despite clinical and pathological similarities. Although susceptibility in heritable PAH and idiopathic PAH is strongly associated with gene mutations leading to reduced expression of bone morphogenetic protein receptor (BMPR) II, these mutations have not been observed in SSc-PAH.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To explore BMPRII expression and function in a mouse model of SSc (T\u03b2RII\u0394k-fib) that is susceptible to developing pulmonary hypertension and in SSc lung.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>BMPRII and downstream signaling pathways were profiled in lung tissue and fibroblasts from the T\u03b2RII\u0394k-fib model, which develops pulmonary vasculopathy with pulmonary hypertension that is exacerbated by SU5416. Complementary studies examined SSc or control lung tissue and fibroblasts.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Measurements and Main Results<\/jats:title>\n                    <jats:p>Our study shows reduced BMPRII, impaired signaling, and altered receptor turnover activity in a transforming growth factor (TGF)-\u03b2\u2013dependent mouse model of SSc-PAH. Similarly, a significant reduction in BMPRII expression is observed in SSc lung tissue and fibroblasts. Increased proteasomal degradation of BMPRII appears to underlie this and may result from heightened TGF-\u03b2 activity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>We found reduced BMPRII protein in patients with SSc-PAH and a relevant mouse model associated with increased proteasomal degradation of BMPRII. Collectively, these results suggest that impaired BMP signaling, resulting from TGF-\u03b2\u2013dependent increased receptor degradation, may promote PAH susceptibility in SSc and provide a unifying mechanism across different forms of PAH.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1164\/rccm.201408-1464oc","type":"journal-article","created":{"date-parts":[[2015,1,21]],"date-time":"2015-01-21T15:44:52Z","timestamp":1421855092000},"page":"665-677","source":"Crossref","is-referenced-by-count":50,"title":["Impaired Bone Morphogenetic Protein Receptor II Signaling in a Transforming Growth Factor-\u03b2\u2013Dependent Mouse Model of Pulmonary Hypertension and in Systemic Sclerosis"],"prefix":"10.1093","volume":"191","author":[{"given":"Adrian J.","family":"Gilbane","sequence":"first","affiliation":[{"name":"Centre for Rheumatology, University College London Division of Medicine, Royal Free Campus, London, United Kingdom; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Derrett-Smith","sequence":"additional","affiliation":[{"name":"Centre for Rheumatology, University College London Division of Medicine, Royal Free Campus, London, United Kingdom; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah L.","family":"Trinder","sequence":"additional","affiliation":[{"name":"Centre for Rheumatology, University College London Division of Medicine, Royal Free Campus, London, United Kingdom; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert B.","family":"Good","sequence":"additional","affiliation":[{"name":"Centre for Rheumatology, University College London Division of Medicine, Royal Free Campus, London, United Kingdom; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Pearce","sequence":"additional","affiliation":[{"name":"Respiratory Disease Area, Novartis Institute for BioMedical Research, Horsham, West Sussex, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher P.","family":"Denton","sequence":"additional","affiliation":[{"name":"Centre for Rheumatology, University College London Division of Medicine, Royal Free Campus, London, United Kingdom; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan M.","family":"Holmes","sequence":"additional","affiliation":[{"name":"Centre for Rheumatology, University College London Division of Medicine, Royal Free Campus, London, United Kingdom; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2015,3,15]]},"reference":[{"key":"2026032100194015400_bib1","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/ar4230","article-title":"Scleroderma pathogenesis: a pivotal role for fibroblasts as effector cells","volume":"15","author":"Gilbane","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"2026032100194015400_bib2","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.3899\/jrheum.100245","article-title":"Prevalence of pulmonary hypertension in systemic sclerosis in European Caucasians and metaanalysis of 5 studies","volume":"37","author":"Avouac","year":"2010","journal-title":"J Rheumatol"},{"key":"2026032100194015400_bib3","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1002\/art.38390","article-title":"Prediction of pulmonary complications and long-term survival in systemic sclerosis","volume":"66","author":"Nihtyanova","year":"2014","journal-title":"Arthritis Rheum (Munch)"},{"key":"2026032100194015400_bib4","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1002\/art.22069","article-title":"Clinical differences between idiopathic and scleroderma-related pulmonary hypertension","volume":"54","author":"Fisher","year":"2006","journal-title":"Arthritis Rheum"},{"key":"2026032100194015400_bib5","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/art.24267","article-title":"Survival in pulmonary hypertension associated with the scleroderma spectrum of diseases: impact of interstitial lung disease","volume":"60","author":"Mathai","year":"2009","journal-title":"Arthritis Rheum"},{"key":"2026032100194015400_bib6","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.pharmthera.2012.06.001","article-title":"Targeting TGF-\u03b2 superfamily ligand accessory proteins as novel therapeutics for chronic lung disorders","volume":"135","author":"Budd","year":"2012","journal-title":"Pharmacol Ther"},{"key":"2026032100194015400_bib7","first-page":"2379","article-title":"Pulmonary hypertension in scleroderma spectrum of disease: lack of bone morphogenetic protein receptor 2 mutations","volume":"29","author":"Morse","year":"2002","journal-title":"J Rheumatol"},{"key":"2026032100194015400_bib8","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1111\/jcmm.12105","article-title":"Epigenetic repression of bone morphogenetic protein receptor II expression in scleroderma","volume":"17","author":"Wang","year":"2013","journal-title":"J Cell Mol Med"},{"key":"2026032100194015400_bib9","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1258\/ebm.2010.009383","article-title":"Smurf1 ubiquitin ligase causes downregulation of BMP receptors and is induced in monocrotaline and hypoxia models of pulmonary arterial hypertension","volume":"235","author":"Murakami","year":"2010","journal-title":"Exp Biol Med (Maywood)"},{"key":"2026032100194015400_bib10","doi-asserted-by":"crossref","first-page":"L604","DOI":"10.1152\/ajplung.00309.2011","article-title":"BMP type II receptor deficiency confers resistance to growth inhibition by TGF-\u03b2 in pulmonary artery smooth muscle cells: role of proinflammatory cytokines","volume":"302","author":"Davies","year":"2012","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"2026032100194015400_bib11","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1161\/CIRCULATIONAHA.108.821504","article-title":"Altered bone morphogenetic protein and transforming growth factor-beta signaling in rat models of pulmonary hypertension: potential for activin receptor-like kinase-5 inhibition in prevention and progression of disease","volume":"119","author":"Long","year":"2009","journal-title":"Circulation"},{"key":"2026032100194015400_bib12","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1164\/rccm.200712-1807OC","article-title":"Clinical outcomes of pulmonary arterial hypertension in carriers of BMPR2 mutation","volume":"177","author":"Sztrymf","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032100194015400_bib13","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1093\/rheumatology\/kes191","article-title":"Gut fibrosis with altered colonic contractility in a mouse model of scleroderma","volume":"51","author":"Thoua","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"2026032100194015400_bib14","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1164\/rccm.201002-0279OC","article-title":"An essential role for resident fibroblasts in experimental lung fibrosis is defined by lineage-specific deletion of high-affinity type II transforming growth factor \u03b2 receptor","volume":"183","author":"Hoyles","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032100194015400_bib15","doi-asserted-by":"crossref","first-page":"R69","DOI":"10.1186\/ar2986","article-title":"Systemic vasculopathy with altered vasoreactivity in a transgenic mouse model of scleroderma","volume":"12","author":"Derrett-Smith","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"2026032100194015400_bib16","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1002\/art.38078","article-title":"Endothelial injury in a transforming growth factor-beta dependent mouse model of scleroderma induces pulmonary arterial hypertension","volume":"65","author":"Derrett-Smith","year":"2013","journal-title":"Arthritis Rheum"},{"key":"2026032100194015400_bib17","doi-asserted-by":"crossref","first-page":"25109","DOI":"10.1074\/jbc.M300636200","article-title":"Fibroblast-specific expression of a kinase-deficient type II transforming growth factor beta (TGF-beta) receptor leads to paradoxical activation of TGF-beta signaling pathways with fibrosis in transgenic mice","volume":"278","author":"Denton","year":"2003","journal-title":"J Biol Chem"},{"key":"2026032100194015400_bib18","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1096\/fj.00-0343com","article-title":"Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death-dependent pulmonary endothelial cell proliferation and severe pulmonary hypertension","volume":"15","author":"Taraseviciene-Stewart","year":"2001","journal-title":"FASEB J"},{"key":"2026032100194015400_bib19","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1164\/rccm.201103-0412OC","article-title":"A novel murine model of severe pulmonary arterial hypertension","volume":"184","author":"Ciuclan","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032100194015400_bib20","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1046\/j.1523-1747.2001.01256.x","article-title":"Fibroblast matrix gene expression and connective tissue remodeling: role of endothelin-1","volume":"116","author":"Shi-Wen","year":"2001","journal-title":"J Invest Dermatol"},{"key":"2026032100194015400_bib21","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1002\/art.23379","article-title":"Fibroblast-specific perturbation of transforming growth factor beta signaling provides insight into potential pathogenic mechanisms of scleroderma-associated lung fibrosis: exaggerated response to alveolar epithelial injury in a novel mouse model","volume":"58","author":"Hoyles","year":"2008","journal-title":"Arthritis Rheum"},{"key":"2026032100194015400_bib22","doi-asserted-by":"crossref","first-page":"RESEARCH0034","DOI":"10.1186\/gb-2002-3-7-research0034","article-title":"Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes","volume":"3","author":"Vandesompele","year":"2002","journal-title":"Genome Biol"},{"key":"2026032100194015400_bib23","doi-asserted-by":"crossref","first-page":"37641","DOI":"10.1074\/jbc.M110.132415","article-title":"Identification of a lysosomal pathway regulating degradation of the bone morphogenetic protein receptor type II","volume":"285","author":"Durrington","year":"2010","journal-title":"J Biol Chem"},{"key":"2026032100194015400_bib24","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1002\/art.37838","article-title":"Borderline mean pulmonary artery pressure in patients with systemic sclerosis: transpulmonary gradient predicts risk of developing pulmonary hypertension","volume":"65","author":"Valerio","year":"2013","journal-title":"Arthritis Rheum"},{"key":"2026032100194015400_bib25","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1164\/rccm.200602-165OC","article-title":"High frequency of BMPR2 exonic deletions\/duplications in familial pulmonary arterial hypertension","volume":"174","author":"Cogan","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032100194015400_bib26","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/humu.9398","article-title":"BMPR2 gene rearrangements account for a significant proportion of mutations in familial and idiopathic pulmonary arterial hypertension","volume":"27","author":"Aldred","year":"2006","journal-title":"Hum Mutat"},{"key":"2026032100194015400_bib27","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1165\/rcmb.2012-0049OC","article-title":"Inhibition of overactive transforming growth factor-\u03b2 signaling by prostacyclin analogs in pulmonary arterial hypertension","volume":"48","author":"Ogo","year":"2013","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2026032100194015400_bib28","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1002\/art.11157","article-title":"Expression and regulation of intracellular SMAD signaling in scleroderma skin fibroblasts","volume":"48","author":"Mori","year":"2003","journal-title":"Arthritis Rheum"},{"key":"2026032100194015400_bib29","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1164\/rccm.200311-1602OC","article-title":"Impaired transforming growth factor-beta signaling in idiopathic pulmonary arterial hypertension","volume":"170","author":"Richter","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032100194015400_bib30","doi-asserted-by":"crossref","first-page":"380","DOI":"10.2353\/ajpath.2009.080565","article-title":"Activin-like kinase 5 (ALK5) mediates abnormal proliferation of vascular smooth muscle cells from patients with familial pulmonary arterial hypertension and is involved in the progression of experimental pulmonary arterial hypertension induced by monocrotaline","volume":"174","author":"Thomas","year":"2009","journal-title":"Am J Pathol"},{"key":"2026032100194015400_bib31","doi-asserted-by":"crossref","first-page":"L209","DOI":"10.1152\/ajplung.00171.2002","article-title":"Alterations in TGF-beta1 expression in lambs with increased pulmonary blood flow and pulmonary hypertension","volume":"285","author":"Mata-Greenwood","year":"2003","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"2026032100194015400_bib32","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1161\/hc3201.094152","article-title":"Altered growth responses of pulmonary artery smooth muscle cells from patients with primary pulmonary hypertension to transforming growth factor-beta(1) and bone morphogenetic proteins","volume":"104","author":"Morrell","year":"2001","journal-title":"Circulation"},{"key":"2026032100194015400_bib33","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1161\/01.RES.0000166926.54293.68","article-title":"Dysfunctional Smad signaling contributes to abnormal smooth muscle cell proliferation in familial pulmonary arterial hypertension","volume":"96","author":"Yang","year":"2005","journal-title":"Circ Res"},{"key":"2026032100194015400_bib34","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1136\/thoraxjnl-2011-200717","article-title":"Proteasomal inhibition after injury prevents fibrosis by modulating TGF-\u03b2(1) signalling","volume":"67","author":"Mutlu","year":"2012","journal-title":"Thorax"},{"key":"2026032100194015400_bib35","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1161\/CIRCRESAHA.111.300483","article-title":"Chloroquine prevents progression of experimental pulmonary hypertension via inhibition of autophagy and lysosomal bone morphogenetic protein type II receptor degradation","volume":"112","author":"Long","year":"2013","journal-title":"Circ Res"},{"key":"2026032100194015400_bib36","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1096\/fj.04-1743fje","article-title":"Ubiquitin-dependent lysosomal degradation of the HNE-modified proteins in lens epithelial cells","volume":"18","author":"Marques","year":"2004","journal-title":"FASEB J"}],"container-title":["American Journal of Respiratory and Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/191\/6\/665\/67231010\/ajrccm_191_6_665.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/191\/6\/665\/67231010\/ajrccm_191_6_665.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T04:20:04Z","timestamp":1774066804000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajrccm\/article\/191\/6\/665\/8504933"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":36,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2015,3,15]]},"published-print":{"date-parts":[[2015,3,15]]}},"URL":"https:\/\/doi.org\/10.1164\/rccm.201408-1464oc","relation":{},"ISSN":["1073-449X","1535-4970"],"issn-type":[{"value":"1073-449X","type":"print"},{"value":"1535-4970","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2015,3]]},"published":{"date-parts":[[2015,3]]}}}